Sale disclosed
Rachna Khosla
SVP, Business Development
Common Stock
- Reported value
- $825.13K
- Reported price
- $412.567 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
AMGEN INC
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
SVP, Business Development
Common Stock
SVP, Business Development
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
SVP, Business Development
Common Stock
SVP, Business Development
Nqso (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
VP, Finance & CAO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP, Human Resources
Common Stock
SVP, Human Resources
Common Stock
SVP, Human Resources
Common Stock
SVP, Human Resources
Common Stock
SVP, Human Resources
Nqso (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP, Human Resources
Nqso (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP & CCO
Common Stock
SVP & CCO
Common Stock
SVP & CCO
Common Stock
SVP & CCO
Common Stock
SVP & CCO
Nqso (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP & CCO
Nqso (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| SVP, Business Development | Common StockSale | 2,000$412.57 / share | $825.13K | Aug 11Filed Aug 13 · 2d later | SEC filing |
| SVP, Business Development | Common StockOption exercise or conversion | 1,252$162.60 / share | $203.58K | Aug 13Filed Aug 13 · 0d later | SEC filing |
| SVP, Business Development | Common StockSale | 1,252$416.43 / share | $521.36K | Aug 13Filed Aug 13 · 0d later | SEC filing |
| SVP, Business Development | Nqso (Right to Buy)Option exercise or conversion | Derivative units1,252$162.60 exercise / conversion price | Not a separate purchase | Aug 13Filed Aug 13 · 0d later | SEC filing |
| VP, Finance & CAO | Common StockGrant or award | 730Award · no purchase price | Non-cash award | Aug 7Filed Aug 12 · 5d later | SEC filing |
| Director | Common StockGrant or award | 85Award · no purchase price | Non-cash award | Aug 7Filed Aug 10 · 3d later | SEC filing |
| Director | Common StockGrant or award | 103Award · no purchase price | Non-cash award | Aug 7Filed Aug 10 · 3d later | SEC filing |
| Director | Common StockGrant or award | 64Award · no purchase price | Non-cash award | Aug 7Filed Aug 10 · 3d later | SEC filing |
| SVP, Human Resources | Common StockOption exercise or conversion | 2,069$162.60 / share | $336.42K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP, Human Resources | Common StockSale | 2,069$402.54 / share | $832.86K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP, Human Resources | Common StockOption exercise or conversion | 1,821$177.46 / share | $323.15K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP, Human Resources | Common StockSale | 1,821$402.54 / share | $733.03K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP, Human Resources | Nqso (Right to Buy)Option exercise or conversion | Derivative units2,069$162.60 exercise / conversion price | Not a separate purchase | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP, Human Resources | Nqso (Right to Buy)Option exercise or conversion | Derivative units1,821$177.46 exercise / conversion price | Not a separate purchase | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP & CCO | Common StockOption exercise or conversion | 1,970$177.46 / share | $349.6K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP & CCO | Common StockSale | 1,970$402.16 / share | $792.26K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP & CCO | Common StockOption exercise or conversion | 1,000$177.31 / share | $177.31K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP & CCO | Common StockSale | 1,000$402.16 / share | $402.16K | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP & CCO | Nqso (Right to Buy)Option exercise or conversion | Derivative units1,970$177.46 exercise / conversion price | Not a separate purchase | Aug 6Filed Aug 7 · 1d later | SEC filing |
| SVP & CCO | Nqso (Right to Buy)Option exercise or conversion | Derivative units1,000$177.31 exercise / conversion price | Not a separate purchase | Aug 6Filed Aug 7 · 1d later | SEC filing |
Showing the latest 20 of 99 trades. Show all 99 trades
Amgen Inc. - Common Stock (AMGN) · Stock
The filing reports a purchase for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock · Stock
The filing reports a partial sale for a spouse.
Sheldon WhitehouseReporting Senate memberAmgen Inc · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberAmgen Inc. - Common Stock · Stock
The filing reports a full sale for the member.
Amgen Inc. - Common Stock (AMGN) · Stock
The filing reports a purchase for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for the member.
Maria Elvira SalazarReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a purchase for the member.
Maria Elvira SalazarReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a purchase for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for the member.
Julia LetlowReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a purchase for the member.
Julia LetlowReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a purchase for the member.
Marjorie Taylor GreeneReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a sale for a spouse.
Lisa McClainReporting House memberAmgen Inc. - Common Stock (AMGN) · Stock
The filing reports a purchase for the member.
Marjorie Taylor GreeneReporting House member